Reduced Exposure Study Using the CHTP 1.2 With 5 Days in a Confinement Setting Followed by 85 Days in an Ambulatory Setting.
A Randomized, Controlled, Open-label, 2-arm Parallel Group, Single Center Study to Demonstrate Reductions in Exposure to Selected Smoke Constituents in Healthy Smokers Switching to the Carbon Heated Tobacco Product 1.2 (CHTP 1.2), Compared to Continuing to Use Combustible Cigarettes, for 5 Days in Confinement Followed by 85 Days in an Ambulatory Setting.
Sponsor: Philip Morris Products S.A.
This NA trial investigates Smoking and is currently completed. Philip Morris Products S.A. leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2023 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Mar 2023 [monthly]
Completed NA
-
Apr 2020 — Jan 2021 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Apr 2019 — Apr 2020 [monthly]
Completed NA
-
Jun 2018 — Apr 2019 [monthly]
Completed NA
-
Dec 2017 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
May 2017 — Dec 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Active Not Recruiting NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Philip Morris Products S.A.
For direct contact, visit the study record on ClinicalTrials.gov .